Cereno Scientific publishes interim report for Q2 2021
The Board and Chief Executive Officer of Cereno Scientific AB here presents the interim report for Q2, 1 April – 30 June, 2021.Summary of the second quarter, April – June 2021 Cereno Scientific Group Second quarter (1 April – 30 June 2021) · Net Sales were SEK 0 (0) · Result after financial items was SEK -4 756 911 (-4 021 921) · Earnings per share was SEK -0.07 (-0.1) before dilution and SEK -0.03 (-0.09) after dilution · The equity/assets ratio was 84.5% (94.9%) Parent company Second quarter (1 April – 30 June 2021) · Net sales were SEK 0 (0) · Result